NCT03581279 - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions

Lyme Disease

Interventions

DEVICE

T2Lyme Panel testing

The T2Lyme Panel is an investigational use in vitro diagnostic (IVD) designed to qualitatively detect and identify the major causative agents of Lyme disease (Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, as well as an inclusive Borrelia spp. detection channel) from K2EDTA human whole blood samples.

Trial Locations (2)

54601

Gundersen Health System, La Crosse

02879

South County Internal Medicine, Wakefield